VAR2 Pharma’s CEO, Dr. Ali Salanti, receives the preclinical Kirsten & Freddy Johansen Foundation (KFJ) Award for his life-long contribution to research. With the Award comes 2M DKK to continue the work on moving the preclinical assets forward to the patients at most need. Read more: https://healthsciences.ku.dk/newsfaculty-news/2022/06/that-is-when-i-realised-that-my-research-can-have-a-positive-effect-on-society
